Case Report
Published on 10 May 2024
Case report: A highly active refractory myasthenia gravis with treatment of telitacicept combined with efgartigimod
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Frontiers in Immunology
doi 10.3389/fimmu.2024.1400459
- 3,703 views
- 7 citations